Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | BPI-9016M |
Synonyms | |
Therapy Description |
BPI-9016M is a small molecule that inhibits MET and AXL and has potential anti-tumor activity (PMID: 29028616, J Clin Oncol 2018 36:15_suppl, e21108-e21108, PMID: 31948451). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BPI-9016M | BPI-9016|BPI 9016 | AXL Inhibitor 30 MET Inhibitor 59 | BPI-9016M is a small molecule that inhibits MET and AXL and has potential anti-tumor activity (PMID: 29028616, J Clin Oncol 2018 36:15_suppl, e21108-e21108, PMID: 31948451). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|